Group One Trading, L.P. Oyster Point Pharma, Inc. Transaction History

Group One Trading, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$7.95 - $11.68 $2,655 - $3,901	-334 Reduced 24.4%	1,035 $11,000
Q3 2022 Nov 09, 2022	SELL	$4.41 - $8.38 $3,867 - $7,349	-877 Reduced 39.05%	1,369 $8,000
Q2 2022 Aug 11, 2022	BUY	$3.6 - $11.2 $2,160 - $6,720	600 Added 36.45%	2,246 $10,000
Q1 2022 May 12, 2022	BUY	$8.58 - $17.65 $14,122 - $29,051	1,646 New	1,646 $19,000

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.